CHAPTER 98 Infiltrative Bowel Diseases
Infiltration of the horse’s intestinal tract with inflammatory or neoplastic cells may result in clinical and clinicopathologic signs of disease that are similar regardless of the type of cell involved. Infiltration of the mucosa and submucosa of the gastrointestinal tract with large numbers of normal or neoplastic eosinophils, lymphocytes, macrophages, plasma cells, or basophils is termed infiltrative bowel disease. Regardless of the type of cell involved, horses with infiltrative bowel disease often have protein-losing enteropathy and malabsorption of nutrients, which causes clinical signs that often include weight loss, lethargy, diarrhea, and dependent edema. In some cases, the cause of invasion of inflammatory cells is determined to be parasitism or mycobacterial infection, and in other cases, the infiltrating cells may be identified as neoplastic. For many affected horses, the cause is undetermined, and these diseases are collectively referred to as chronic idiopathic inflammatory bowel disease (CIBD). Four types of CIBD in the horse are recognized: granulomatous enteritis (GE); lymphocytic-plasmacytic enterocolitis (LPE); multisystemic, eosinophilic, epitheliotropic disease (MEED); and idiopathic, focal, eosinophilic enterocolitis (IFEE).
GRANULOMATOUS ENTERITIS
Horses with GE do not respond to administration of drugs used to treat Crohn’s disease in humans, such as salicylazosulfapyridine and methylsulfapyridine. A few horses with GE were reported to respond favorably to treatment with dexamethasone, but long-term survival with any medical treatment has not been reported. Two horses with GE responded favorably to removal of grossly affected ileum and several meters of distal jejunum. Surgical treatment of most horses with GE is unlikely to be beneficial, however, because gross intestinal lesions are usually diffuse and involve long segments of intestine.